Cargando…

Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action

[Image: see text] ATAD2 (ANCCA) is an epigenetic regulator and transcriptional cofactor, whose overexpression has been linked to the progress of various cancer types. Here, we report a DNA-encoded library screen leading to the discovery of BAY-850, a potent and isoform selective inhibitor that speci...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Montalván, Amaury E., Berger, Markus, Kuropka, Benno, Koo, Seong Joo, Badock, Volker, Weiske, Joerg, Puetter, Vera, Holton, Simon J., Stöckigt, Detlef, ter Laak, Antonius, Centrella, Paolo A., Clark, Matthew A., Dumelin, Christoph E., Sigel, Eric A., Soutter, Holly H., Troast, Dawn M., Zhang, Ying, Cuozzo, John W., Keefe, Anthony D., Roche, Didier, Rodeschini, Vincent, Chaikuad, Apirat, Díaz-Sáez, Laura, Bennett, James M., Fedorov, Oleg, Huber, Kilian V. M., Hübner, Jan, Weinmann, Hilmar, Hartung, Ingo V., Gorjánácz, Mátyás
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218015/
https://www.ncbi.nlm.nih.gov/pubmed/29043777
http://dx.doi.org/10.1021/acschembio.7b00708
_version_ 1783368381220519936
author Fernández-Montalván, Amaury E.
Berger, Markus
Kuropka, Benno
Koo, Seong Joo
Badock, Volker
Weiske, Joerg
Puetter, Vera
Holton, Simon J.
Stöckigt, Detlef
ter Laak, Antonius
Centrella, Paolo A.
Clark, Matthew A.
Dumelin, Christoph E.
Sigel, Eric A.
Soutter, Holly H.
Troast, Dawn M.
Zhang, Ying
Cuozzo, John W.
Keefe, Anthony D.
Roche, Didier
Rodeschini, Vincent
Chaikuad, Apirat
Díaz-Sáez, Laura
Bennett, James M.
Fedorov, Oleg
Huber, Kilian V. M.
Hübner, Jan
Weinmann, Hilmar
Hartung, Ingo V.
Gorjánácz, Mátyás
author_facet Fernández-Montalván, Amaury E.
Berger, Markus
Kuropka, Benno
Koo, Seong Joo
Badock, Volker
Weiske, Joerg
Puetter, Vera
Holton, Simon J.
Stöckigt, Detlef
ter Laak, Antonius
Centrella, Paolo A.
Clark, Matthew A.
Dumelin, Christoph E.
Sigel, Eric A.
Soutter, Holly H.
Troast, Dawn M.
Zhang, Ying
Cuozzo, John W.
Keefe, Anthony D.
Roche, Didier
Rodeschini, Vincent
Chaikuad, Apirat
Díaz-Sáez, Laura
Bennett, James M.
Fedorov, Oleg
Huber, Kilian V. M.
Hübner, Jan
Weinmann, Hilmar
Hartung, Ingo V.
Gorjánácz, Mátyás
author_sort Fernández-Montalván, Amaury E.
collection PubMed
description [Image: see text] ATAD2 (ANCCA) is an epigenetic regulator and transcriptional cofactor, whose overexpression has been linked to the progress of various cancer types. Here, we report a DNA-encoded library screen leading to the discovery of BAY-850, a potent and isoform selective inhibitor that specifically induces ATAD2 bromodomain dimerization and prevents interactions with acetylated histones in vitro, as well as with chromatin in cells. These features qualify BAY-850 as a chemical probe to explore ATAD2 biology.
format Online
Article
Text
id pubmed-6218015
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-62180152018-11-05 Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action Fernández-Montalván, Amaury E. Berger, Markus Kuropka, Benno Koo, Seong Joo Badock, Volker Weiske, Joerg Puetter, Vera Holton, Simon J. Stöckigt, Detlef ter Laak, Antonius Centrella, Paolo A. Clark, Matthew A. Dumelin, Christoph E. Sigel, Eric A. Soutter, Holly H. Troast, Dawn M. Zhang, Ying Cuozzo, John W. Keefe, Anthony D. Roche, Didier Rodeschini, Vincent Chaikuad, Apirat Díaz-Sáez, Laura Bennett, James M. Fedorov, Oleg Huber, Kilian V. M. Hübner, Jan Weinmann, Hilmar Hartung, Ingo V. Gorjánácz, Mátyás ACS Chem Biol [Image: see text] ATAD2 (ANCCA) is an epigenetic regulator and transcriptional cofactor, whose overexpression has been linked to the progress of various cancer types. Here, we report a DNA-encoded library screen leading to the discovery of BAY-850, a potent and isoform selective inhibitor that specifically induces ATAD2 bromodomain dimerization and prevents interactions with acetylated histones in vitro, as well as with chromatin in cells. These features qualify BAY-850 as a chemical probe to explore ATAD2 biology. American Chemical Society 2017-10-18 2017-11-17 /pmc/articles/PMC6218015/ /pubmed/29043777 http://dx.doi.org/10.1021/acschembio.7b00708 Text en Copyright © 2017 American Chemical Society This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
spellingShingle Fernández-Montalván, Amaury E.
Berger, Markus
Kuropka, Benno
Koo, Seong Joo
Badock, Volker
Weiske, Joerg
Puetter, Vera
Holton, Simon J.
Stöckigt, Detlef
ter Laak, Antonius
Centrella, Paolo A.
Clark, Matthew A.
Dumelin, Christoph E.
Sigel, Eric A.
Soutter, Holly H.
Troast, Dawn M.
Zhang, Ying
Cuozzo, John W.
Keefe, Anthony D.
Roche, Didier
Rodeschini, Vincent
Chaikuad, Apirat
Díaz-Sáez, Laura
Bennett, James M.
Fedorov, Oleg
Huber, Kilian V. M.
Hübner, Jan
Weinmann, Hilmar
Hartung, Ingo V.
Gorjánácz, Mátyás
Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action
title Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action
title_full Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action
title_fullStr Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action
title_full_unstemmed Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action
title_short Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action
title_sort isoform-selective atad2 chemical probe with novel chemical structure and unusual mode of action
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218015/
https://www.ncbi.nlm.nih.gov/pubmed/29043777
http://dx.doi.org/10.1021/acschembio.7b00708
work_keys_str_mv AT fernandezmontalvanamaurye isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT bergermarkus isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT kuropkabenno isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT kooseongjoo isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT badockvolker isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT weiskejoerg isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT puettervera isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT holtonsimonj isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT stockigtdetlef isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT terlaakantonius isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT centrellapaoloa isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT clarkmatthewa isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT dumelinchristophe isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT sigelerica isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT soutterhollyh isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT troastdawnm isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT zhangying isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT cuozzojohnw isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT keefeanthonyd isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT rochedidier isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT rodeschinivincent isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT chaikuadapirat isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT diazsaezlaura isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT bennettjamesm isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT fedorovoleg isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT huberkilianvm isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT hubnerjan isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT weinmannhilmar isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT hartungingov isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction
AT gorjanaczmatyas isoformselectiveatad2chemicalprobewithnovelchemicalstructureandunusualmodeofaction